Hospitals Lose $3.2 Billion Due To Drug Makers’ 340B Restrictions

By Gabrielle Wanneh / November 15, 2021 at 5:58 PM
Drug companies’ restrictions on 340B program discounts have cost covered hospitals and clinics $3.2 billion annually, according to a footnote buried in a recent federal court ruling on drug company lawsuits against HHS’ effort to make them give 340B discounts to all pharmacies that 340B hospitals contract with. Since October, three federal courts have issued opinions on lawsuits by drug makers against the policy by the Health Resources and Services Administration, which oversees the 340B drug discount program. The opinions...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.